TRCT
PRAX icon

Tower Research Capital (TRC)’s Praxis Precision Medicines PRAX Stock Holding History

Tower Research Capital (TRC)’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$777K Buy
2,322
+989
+74% +$313K 0.02% 762
2026
Q1 		$429K Buy
1,333
+722
+118% +$223K 0.01% 1023
2025
Q4 		$180K Sell
611
-1,516
-71% -$282K ﹤0.01% 1511
2025
Q3 		$113K Buy
2,127
+290
+16% +$14.1K ﹤0.01% 1905
2025
Q2 		$77.2K Buy
1,837
+359
+24% +$13.7K ﹤0.01% 2598
2025
Q1 		$56K Sell
1,478
-4,395
-75% -$274K ﹤0.01% 2154
2024
Q4 		$452K Buy
5,873
+4,990
+565% +$361K 0.01% 1142
2024
Q3 		$50.8K Sell
883
-636
-42% -$34.4K ﹤0.01% 2712
2024
Q2 		$62.8K Sell
1,519
-329
-18% -$15.5K ﹤0.01% 2924
2024
Q1 		$113K Buy
+1,848
New +$82.9K ﹤0.01% 1765
2023
Q3 		– Sell
-746
Closed -$12.9K – 6165
2023
Q2 		$12.9K Sell
746
-75
-9% -$1.15K ﹤0.01% 3825
2023
Q1 		$10K Sell
821
-952
-54% -$40.2K ﹤0.01% 4392
2022
Q4 		$63K Buy
1,773
+637
+56% +$19.9K ﹤0.01% 2169
2022
Q3 		$39K Buy
1,136
+211
+23% +$10.5K ﹤0.01% 3383
2022
Q2 		$34K Buy
925
+611
+195% +$65.2K ﹤0.01% 3252
2022
Q1 		$48K Buy
314
+226
+257% +$46.4K ﹤0.01% 2769
2021
Q4 		$26K Buy
88
+12
+16% +$3.52K ﹤0.01% 3394
2021
Q3 		$21K Sell
76
-210
-73% -$57K ﹤0.01% 3673
2021
Q2 		$78K Buy
286
+217
+314% +$77.7K ﹤0.01% 2629
2021
Q1 		$34K Buy
69
+44
+176% +$31.3K ﹤0.01% 3463
2020
Q4 		$20K Buy
+25
New +$14.6K ﹤0.01% 3877

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Tower Research Capital (TRC)'s PRAX Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Praxis Precision Medicines (PRAX) stake by 74% in Q2 2026, buying an estimated $313K and bringing the position to 2,322 shares worth $777K. The position accounts for 0.02% of the portfolio, ranked #762.

Tower Research Capital (TRC) first reported a position in PRAX in Q4 2020 and has held it in 21 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Tower Research Capital (TRC) held 2,322 shares of Praxis Precision Medicines worth $777K as of Q2 2026.
  • Tower Research Capital (TRC) bought 989 Praxis Precision Medicines shares in Q2 2026, an estimated $313K.
  • Praxis Precision Medicines made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #762 holding.
  • Tower Research Capital (TRC) first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 21 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.